Clinical trials: Rhinorrhea
Chronic Rhinitis
A Randomized Double Dummy Double Blind Dose Determining Place-bo Controlled Study to Evaluate Efficacy of Investigational Product E-RH-06 at 2 Dose Levels for the Metabolic Management of Chronic or Recurrent, Non-infective Nasal Congestion With-or-without Rhinorrhea.
The study will be conducted in two phases. First phase will be 16 weeks study to assess the safety, efficacy \& to determine the most appropriate dose. Will consist of following visits.
- Trial name
- EB-RH-02-11 (NCT01546662)
- Testing
- E-RH-06
- Where
- 4 sites in India
- Volunteers
- 54 people
- Sponsor
- Enovate Biolife Pvt Ltd